Investigational drug · Phase 2
Invobenitug also known as Procizumab
Also called: AK1967
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Shock, Cardiogenic.
Phase 2Last checked: Nov 20, 2026Latest source record: Sep 14, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "Invobenitug also known as Procizumab"
First trial start
2025
Jul 13, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "Invobenitug also known as Procizumab", any sponsor or status.
Conditions studied
As listed on its trial records.
- Shock, Cardiogenic
Approved drugs for the same conditions: Cardiovascular and metabolic
Largest trials
Live from ClinicalTrials.gov: studies naming "Invobenitug also known as Procizumab" as an intervention, largest first.
4TEEN4 Pharmaceuticals GmbHIndustry
NCT06832722 · 90 participants (planned) · Start Jul 13, 2025 · Primary completion Dec 30, 2026
Drug: AK1967 (Invobenitug also known as Procizumab); Placebo · For: Shock, Cardiogenic
Sites: Yerevan, Armenia; Aalst, Belgium; Brussels, Belgium · 37 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3.
Genest M, Van Lier D, Uba TI, et al. · MAbs 2026
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.